A detailed history of Integral Health Asset Management, LLC transactions in Insmed Inc stock. As of the latest transaction made, Integral Health Asset Management, LLC holds 1,450,000 shares of INSM stock, worth $102 Million. This represents 12.45% of its overall portfolio holdings.

Number of Shares
1,450,000
Previous 1,550,000 6.45%
Holding current value
$102 Million
Previous $104 Million 1.93%
% of portfolio
12.45%
Previous 9.98%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$62.0 - $79.01 $6.2 Million - $7.9 Million
-100,000 Reduced 6.45%
1,450,000 $106 Million
Q2 2024

Aug 14, 2024

BUY
$22.0 - $69.71 $5.5 Million - $17.4 Million
250,000 Added 19.23%
1,550,000 $104 Million
Q1 2024

May 15, 2024

BUY
$25.72 - $29.94 $24.4 Million - $28.4 Million
950,000 Added 271.43%
1,300,000 $35.3 Million
Q4 2023

Feb 14, 2024

BUY
$23.42 - $31.74 $8.2 Million - $11.1 Million
350,000 New
350,000 $10.8 Million
Q2 2022

Aug 03, 2022

SELL
$17.07 - $25.71 $778,921 - $1.17 Million
-45,631 Reduced 30.42%
104,369 $2.06 Million
Q1 2022

May 12, 2022

BUY
$20.42 - $28.13 $1.43 Million - $1.97 Million
70,000 Added 87.5%
150,000 $3.53 Million
Q4 2021

Feb 02, 2022

SELL
$25.89 - $33.45 $517,800 - $669,000
-20,000 Reduced 20.0%
80,000 $2.18 Million
Q3 2021

Nov 12, 2021

BUY
$22.46 - $29.47 $2.25 Million - $2.95 Million
100,000 New
100,000 $2.75 Million
Q2 2021

Aug 13, 2021

SELL
$24.17 - $36.01 $1.69 Million - $2.52 Million
-70,000 Closed
0 $0
Q1 2021

May 10, 2021

BUY
$32.28 - $44.3 $645,600 - $886,000
20,000 Added 40.0%
70,000 $2.38 Million
Q4 2020

Feb 16, 2021

BUY
$31.45 - $40.54 $786,250 - $1.01 Million
25,000 Added 100.0%
50,000 $1.67 Million
Q3 2020

Nov 16, 2020

BUY
$26.0 - $34.5 $650,000 - $862,500
25,000 New
25,000 $804,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.56B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Integral Health Asset Management, LLC Portfolio

Follow Integral Health Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integral Health Asset Management, LLC with notifications on news.